Biosimilars represent a meaningful opportunity to reduce drug spending by as much as $375 billion over the next decade. Cigna is committed to driving greater value and lower costs where clinically appropriate for our customers and clients. As a longtime advocate for greater availability of biosimilars, we have worked for a decade to advance the pathways needed to bring biosimilars to market.

At Cigna, our diabetes care solutions are built around a whole-person health strategy. The aim is to help identify, prevent and manage diabetes by connecting individuals to the right level of care. We look at some of the ways our approach has helped patients save money, and improves medication adherence and health outcomes.

Cigna’s leaders gathered recently in New York City for our first in-person Investor Day since the pandemic began. Chairman and Chief Executive Officer David Cordani and other company leaders spoke with the investment community and shareholders, illustrating the many ways we are delivering on our mission and investing in a rapidly changing future.

Patients may not be aware that infusion centers are quality sites of care that are often more affordable options for receiving infusions for complex conditions such as cancer, rheumatoid arthritis, hemophilia, and hepatitis C.

Cigna Chairman and CEO David Cordani sat down with Arianna Huffington, CEO of Thrive Global, to talk about worsening mental health among teens, the promise of pharmacological innovation, virtual care and the profound power of micro-communities.

When employers select health plan networks for their employees, they may look at the pure size of a network and assume the more doctors, hospitals, and clinics that are included, the better. However, size alone does not equal quality. The quality of care a patient receives is critical in managing the total cost of care, which includes medical, pharmacy, and behavioral care costs.

According to new research from AHIP, the cost to patients and their health plans is particularly high when specialty drugs are administered to patients in a hospital setting. The key finding: Specialty pharmacies are the more affordable option.

Cigna has announced an additional $450 million investment in Cigna Ventures, our corporate venture fund focused on finding and partnering with health tech startups as they look to become a catalyst for bold new opportunities to improve people's health and make health care more affordable, simple, and predictable.

Prior authorization – also called preauthorization, preapproval, and precertification – is a tool that helps health plans protect patient health and safety and improve affordability by reducing unnecessary costs.

To better understand the virtual care landscape we sat down with Dr. William Lopez, national medical director for virtual care at Evernorth, Cigna Corporation’s health services business. Read on to get some insights around how virtual care will augment and complement the health care experience.